Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Vericel (VCEL)

Vericel Q3 Revenue Rises 27% to $57.9 Million; Full-Year Profitability Guidance Raised

Positive Impact 4 of 5 earnings Written later

Vericel reported third-quarter 2024 total revenue of $57.9 million, up 27%, and a net loss of $0.9 million, or $0.02 per diluted share, compared with a $3.7 million loss a year earlier. The company raised its full-year profitability guidance to a 72% gross margin and 22% adjusted EBITDA margin, while keeping its full-year revenue guidance of $238 to $242 million, so shareholders see stronger margins but the company still reported a net loss.

Key points

  • Q3 total revenue of $57.9 million, up from $45.6 million; MACI revenue $44.7 million and Burn Care revenue $13.2 million
  • Q3 gross margin of 72%, up from 67%; operating expenses rose to $44.1 million from $35.7 million
  • Q3 net loss of $0.9 million, or $0.02 per diluted share, versus $3.7 million, or $0.08 per share, in Q3 2023
  • Full-year profitability guidance raised to 72% gross margin and 22% adjusted EBITDA margin, from 71% and 21%; revenue guidance maintained at $238 to $242 million

The filing

CompanyVericel (VCEL)
Form8-K, current report
Filed with the SECNov 7, 2024, 8:01 AM ET
Accession number0001628280-24-045997

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 07, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.